vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and WSFS FINANCIAL CORP (WSFS). Click either name above to swap in a different company.

WSFS FINANCIAL CORP is the larger business by last-quarter revenue ($275.3M vs $270.8M, roughly 1.0× HUTCHMED (China) Ltd). WSFS FINANCIAL CORP runs the higher net margin — 31.5% vs 0.7%, a 30.8% gap on every dollar of revenue. On growth, WSFS FINANCIAL CORP posted the faster year-over-year revenue change (7.5% vs -16.5%).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

WSFS Financial Corporation is a financial services company. Its primary subsidiary, WSFS Bank, a federal savings bank, is the largest and longest-standing locally managed bank and wealth management franchise headquartered in Delaware and the Greater Delaware Valley. WSFS operates from 115 offices, 88 of which are banking offices, located in Pennsylvania (57), Delaware (39), New Jersey (14), Florida (2), Virginia (1), and Nevada (1) and provides comprehensive financial services including comme...

HCM vs WSFS — Head-to-Head

Bigger by revenue
WSFS
WSFS
1.0× larger
WSFS
$275.3M
$270.8M
HCM
Growing faster (revenue YoY)
WSFS
WSFS
+24.0% gap
WSFS
7.5%
-16.5%
HCM
Higher net margin
WSFS
WSFS
30.8% more per $
WSFS
31.5%
0.7%
HCM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HCM
HCM
WSFS
WSFS
Revenue
$270.8M
$275.3M
Net Profit
$2.0M
$86.8M
Gross Margin
37.7%
Operating Margin
-13.2%
Net Margin
0.7%
31.5%
Revenue YoY
-16.5%
7.5%
Net Profit YoY
-83.6%
31.7%
EPS (diluted)
$0.00
$1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
WSFS
WSFS
Q1 26
$275.3M
Q4 25
$270.8M
$271.9M
Q3 25
$270.5M
Q2 25
$277.7M
$267.5M
Q1 25
$324.5M
$256.1M
Q4 24
$261.5M
Q3 24
$267.7M
Q2 24
$305.7M
$266.0M
Net Profit
HCM
HCM
WSFS
WSFS
Q1 26
$86.8M
Q4 25
$2.0M
$72.7M
Q3 25
$76.4M
Q2 25
$455.0M
$72.3M
Q1 25
$11.9M
$65.9M
Q4 24
$64.2M
Q3 24
$64.4M
Q2 24
$25.8M
$69.3M
Gross Margin
HCM
HCM
WSFS
WSFS
Q1 26
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Operating Margin
HCM
HCM
WSFS
WSFS
Q1 26
Q4 25
-13.2%
35.8%
Q3 25
37.3%
Q2 25
-1.3%
35.7%
Q1 25
-5.0%
34.0%
Q4 24
32.3%
Q3 24
31.9%
Q2 24
-9.0%
34.0%
Net Margin
HCM
HCM
WSFS
WSFS
Q1 26
31.5%
Q4 25
0.7%
26.7%
Q3 25
28.3%
Q2 25
163.8%
27.0%
Q1 25
3.7%
25.7%
Q4 24
24.6%
Q3 24
24.1%
Q2 24
8.4%
26.0%
EPS (diluted)
HCM
HCM
WSFS
WSFS
Q1 26
$1.64
Q4 25
$0.00
$1.33
Q3 25
$1.37
Q2 25
$0.52
$1.27
Q1 25
$0.01
$1.12
Q4 24
$1.08
Q3 24
$1.08
Q2 24
$0.03
$1.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
WSFS
WSFS
Cash + ST InvestmentsLiquidity on hand
$1.4B
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$2.7B
Total Assets
$1.8B
$22.1B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
WSFS
WSFS
Q1 26
Q4 25
$1.4B
$1.7B
Q3 25
Q2 25
$1.4B
Q1 25
$836.1M
Q4 24
$1.2B
Q3 24
Q2 24
$802.5M
Total Debt
HCM
HCM
WSFS
WSFS
Q1 26
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Stockholders' Equity
HCM
HCM
WSFS
WSFS
Q1 26
$2.7B
Q4 25
$1.2B
$2.7B
Q3 25
$2.8B
Q2 25
$1.2B
$2.7B
Q1 25
$759.9M
$2.7B
Q4 24
$2.6B
Q3 24
$2.7B
Q2 24
$740.1M
$2.5B
Total Assets
HCM
HCM
WSFS
WSFS
Q1 26
$22.1B
Q4 25
$1.8B
$21.3B
Q3 25
$20.8B
Q2 25
$1.8B
$20.8B
Q1 25
$1.3B
$20.5B
Q4 24
$20.8B
Q3 24
$20.9B
Q2 24
$1.3B
$20.7B
Debt / Equity
HCM
HCM
WSFS
WSFS
Q1 26
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
WSFS
WSFS
Operating Cash FlowLast quarter
$8.2M
Free Cash FlowOCF − Capex
$3.4M
FCF MarginFCF / Revenue
1.2%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
WSFS
WSFS
Q1 26
Q4 25
$8.2M
$220.0M
Q3 25
$121.5M
Q2 25
$-72.9M
$37.2M
Q1 25
$40.3M
$8.7M
Q4 24
$219.9M
Q3 24
$3.1M
Q2 24
$-39.8M
$44.8M
Free Cash Flow
HCM
HCM
WSFS
WSFS
Q1 26
Q4 25
$3.4M
$213.6M
Q3 25
$120.3M
Q2 25
$-82.2M
$35.2M
Q1 25
$32.5M
$6.3M
Q4 24
$205.6M
Q3 24
$-489.0K
Q2 24
$-49.9M
$42.1M
FCF Margin
HCM
HCM
WSFS
WSFS
Q1 26
Q4 25
1.2%
78.6%
Q3 25
44.5%
Q2 25
-29.6%
13.2%
Q1 25
10.0%
2.5%
Q4 24
78.6%
Q3 24
-0.2%
Q2 24
-16.3%
15.8%
Capex Intensity
HCM
HCM
WSFS
WSFS
Q1 26
Q4 25
1.8%
2.3%
Q3 25
0.5%
Q2 25
3.3%
0.7%
Q1 25
2.4%
0.9%
Q4 24
5.5%
Q3 24
1.4%
Q2 24
3.3%
1.0%
Cash Conversion
HCM
HCM
WSFS
WSFS
Q1 26
Q4 25
4.21×
3.03×
Q3 25
1.59×
Q2 25
-0.16×
0.51×
Q1 25
3.38×
0.13×
Q4 24
3.43×
Q3 24
0.05×
Q2 24
-1.54×
0.65×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons